COVID-19 after the first wave of the pandemic among employees from a German university hospital : prevalence and questionnaire data
©2022 JOURNAL of MEDICINE and LIFE..
The SARS-CoV-2 pandemic has changed lives around the world. In particular, healthcare workers faced significant challenges as a result of the pandemic. This study investigates the seroprevalence of SARS-CoV-2 in March-April 2020 in Germany among healthcare workers and relates it to questionnaire data. In June 2020, all employees of the reporting hospital were offered a free SARS-CoV-2 antibody test. The first 2,550 test results were sent along with study documents. The response rate was 15.1%. The COVID-19 PCR test prevalence amongst health care workers in this study was 1.04% (95% CI 0.41-2.65%), higher by a factor of 5 than in the general population (p=0.01). The ratio of seroprevalence to PCR prevalence was 1.5. COVID-19-associated symptoms were also prevalent in the non-COVID-19-positive population. Only two symptoms showed statistically significant odds ratios, loss of smell and loss of taste. Health care workers largely supported non-pharmaceutical interventions during the initial lockdown (93%). Individual behavior correlated significantly with attitudes toward policy interventions and perceived individual risk factors. Our data suggest that healthcare workers may be at higher risk of infection. Therefore, a discussion about prioritizing vaccination makes sense. They also support offering increased SARS-CoV-2 testing to hospital workers. It is concluded that easier access to SARS-CoV-2 testing reduces the number of unreported cases. Furthermore, individual attitudes toward rules and regulations on COVID-19 critically influence compliance. Thus, one goal of public policy should be to maintain high levels of support for non-pharmaceutical interventions to keep actual compliance high.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Journal of medicine and life - 15(2022), 9 vom: 22. Sept., Seite 1119-1128 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sellmeier, Anna Catharina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 24.11.2022 Date Revised 24.11.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.25122/jml-2022-0126 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349286264 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349286264 | ||
| 003 | DE-627 | ||
| 005 | 20231226042247.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.25122/jml-2022-0126 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1164.xml |
| 035 | |a (DE-627)NLM349286264 | ||
| 035 | |a (NLM)36415516 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sellmeier, Anna Catharina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 after the first wave of the pandemic among employees from a German university hospital |b prevalence and questionnaire data |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.11.2022 | ||
| 500 | |a Date Revised 24.11.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a ©2022 JOURNAL of MEDICINE and LIFE. | ||
| 520 | |a The SARS-CoV-2 pandemic has changed lives around the world. In particular, healthcare workers faced significant challenges as a result of the pandemic. This study investigates the seroprevalence of SARS-CoV-2 in March-April 2020 in Germany among healthcare workers and relates it to questionnaire data. In June 2020, all employees of the reporting hospital were offered a free SARS-CoV-2 antibody test. The first 2,550 test results were sent along with study documents. The response rate was 15.1%. The COVID-19 PCR test prevalence amongst health care workers in this study was 1.04% (95% CI 0.41-2.65%), higher by a factor of 5 than in the general population (p=0.01). The ratio of seroprevalence to PCR prevalence was 1.5. COVID-19-associated symptoms were also prevalent in the non-COVID-19-positive population. Only two symptoms showed statistically significant odds ratios, loss of smell and loss of taste. Health care workers largely supported non-pharmaceutical interventions during the initial lockdown (93%). Individual behavior correlated significantly with attitudes toward policy interventions and perceived individual risk factors. Our data suggest that healthcare workers may be at higher risk of infection. Therefore, a discussion about prioritizing vaccination makes sense. They also support offering increased SARS-CoV-2 testing to hospital workers. It is concluded that easier access to SARS-CoV-2 testing reduces the number of unreported cases. Furthermore, individual attitudes toward rules and regulations on COVID-19 critically influence compliance. Thus, one goal of public policy should be to maintain high levels of support for non-pharmaceutical interventions to keep actual compliance high | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a antibody | |
| 650 | 4 | |a health care workers | |
| 700 | 1 | |a Elsner, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Niedergassel, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Schmitz, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Rehberg, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Hornberg, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Vordemvenne, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Wähnert, Dirk |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medicine and life |d 2008 |g 15(2022), 9 vom: 22. Sept., Seite 1119-1128 |w (DE-627)NLM19467049X |x 1844-3117 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2022 |g number:9 |g day:22 |g month:09 |g pages:1119-1128 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.25122/jml-2022-0126 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2022 |e 9 |b 22 |c 09 |h 1119-1128 | ||